logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

XUANWU CLOUD (02392) spent 8,605.08 Hong Kong dollars to repurchase 6,000 shares on February 3rd.

date
19:10 03/02/2026
avatar
GMT Eight
Xuanwu Cloud (02392) announced that on February 3, 2026, it spent HK$8,605.08 to repurchase 6,000 shares.
XUANWU CLOUD (02392) announced on February 3, 2026, the repurchase of 6,000 shares at a cost of 8,605.08 Hong Kong dollars.
Related Articles
HK Stock
QIDIAN GUOFENG (01280) completes issuance of 1.975 million shares to acquire AI company
HK Stock
The innovative drug CMS-D017 capsule developed independently by CMS(00867) has obtained the approval notification for clinical trial of drugs for renal diseases mediated by complement participation adaptation.
HK Stock
GF SEC(01776): "25 GF D8" will be issued on February 5th with dividends and delisting.
QIDIAN GUOFENG (01280) completes issuance of 1.975 million shares to acquire AI company
HK Stock
The innovative drug CMS-D017 capsule developed independently by CMS(00867) has obtained the approval notification for clinical trial of drugs for renal diseases mediated by complement participation adaptation.
HK Stock
GF SEC(01776): "25 GF D8" will be issued on February 5th with dividends and delisting.
HK Stock
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
icon
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
icon
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
icon
30/01/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.